From Literature to Hypotheses: An AI Co-Scientist System for Biomarker-Guided Drug Combination Hypothesis Generation
arXiv:2603.00612v1 Announce Type: new Abstract: The rapid growth of biomedical literature and curated databases has made it increasingly difficult for researchers to systematically connect biomarker mechanisms to actionable drug combination hypotheses. We present AI Co-Scientist (CoDHy), an interactive, human-in-the-loop system for biomarker-guided drug combination hypothesis generation in cancer research. CoDHy integrates structured biomedical databases and unstructured literature evidence into a task-specific knowledge graph, which serves as the basis for graph-based reasoning and hypothesis construction. The system combines knowledge graph embeddings with agent-based reasoning to generate, validate, and rank candidate drug combinations, while explicitly grounding each hypothesis in retrievable evidence. Through a web-based interface, users can configure the scientific context, inspect intermediate results, and iteratively refine hypotheses, enabling transparent and researcher-steer
arXiv:2603.00612v1 Announce Type: new Abstract: The rapid growth of biomedical literature and curated databases has made it increasingly difficult for researchers to systematically connect biomarker mechanisms to actionable drug combination hypotheses. We present AI Co-Scientist (CoDHy), an interactive, human-in-the-loop system for biomarker-guided drug combination hypothesis generation in cancer research. CoDHy integrates structured biomedical databases and unstructured literature evidence into a task-specific knowledge graph, which serves as the basis for graph-based reasoning and hypothesis construction. The system combines knowledge graph embeddings with agent-based reasoning to generate, validate, and rank candidate drug combinations, while explicitly grounding each hypothesis in retrievable evidence. Through a web-based interface, users can configure the scientific context, inspect intermediate results, and iteratively refine hypotheses, enabling transparent and researcher-steerable exploration rather than automated decision-making. We demonstrate CoDHy as a system for exploratory hypothesis generation and decision support in translational oncology, highlighting its design, interaction workflow, and practical use cases.
Executive Summary
The article introduces AI Co-Scientist (CoDHy), a human-in-the-loop system for biomarker-guided drug combination hypothesis generation in cancer research. CoDHy integrates biomedical databases and literature evidence into a knowledge graph, enabling graph-based reasoning and hypothesis construction. The system allows users to configure the scientific context, inspect results, and refine hypotheses, providing transparent and researcher-steerable exploration. CoDHy demonstrates potential as a tool for exploratory hypothesis generation and decision support in translational oncology.
Key Points
- ▸ Integration of structured biomedical databases and unstructured literature evidence
- ▸ Graph-based reasoning and hypothesis construction
- ▸ Human-in-the-loop system for transparent and researcher-steerable exploration
Merits
Interdisciplinary Approach
CoDHy's integration of biomedical databases and literature evidence enables a comprehensive understanding of biomarker mechanisms and drug combinations.
Transparency and Explainability
The system's ability to provide explicit evidence grounding for each hypothesis enhances transparency and trust in the generated hypotheses.
Demerits
Complexity and Scalability
CoDHy's reliance on large amounts of data and complex graph-based reasoning may pose scalability challenges and require significant computational resources.
User Expertise
The system's effectiveness may depend on the user's expertise in configuring the scientific context and interpreting results.
Expert Commentary
The introduction of CoDHy marks a significant advancement in the application of artificial intelligence in biomedical research. By leveraging graph-based reasoning and human-in-the-loop design, CoDHy has the potential to accelerate the discovery of effective drug combinations and improve patient outcomes in cancer treatment. However, the system's effectiveness will depend on careful consideration of its limitations, including the need for high-quality data and user expertise. As CoDHy and similar systems continue to evolve, it is essential to address the ethical, regulatory, and social implications of AI-driven healthcare technologies.
Recommendations
- ✓ Further evaluation of CoDHy's performance in real-world clinical settings
- ✓ Development of standardized frameworks for evaluating the safety and efficacy of AI-driven healthcare technologies